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The inhibitory effect of large tumor suppressor kinase (LATS1/2) on the activity of the oncoprotein yes-associated protein (YAP) is cru-
cial to maintain tissue homeostasis. Proteomic studies have identified several new regulators of this process. Recently, citron kinase
(CIT) was listed as a potential binding candidate of Hippo-related components, suggesting a new connection between CIT and the Hippo
pathway. Aside from CIT’s role in cytokinesis, the molecular crosstalk between CIT and the Hippo pathway is largely unknown. Here, we
demonstrate a role for CIT as a scaffold protein linking LATS2 and YAP. More importantly, CIT interacts with LATS2 to directly suppress
LATS2 phosphorylation at the hydrophobic motif—targeted by MST1, leading to LATS2 inactivation and YAP activation. By studying
their genetic interactions, we found that Sticky, the CIT homolog in Drosophila melanogaster, functions with Warts to control Drosophila
eye development. Together, our study confirms citron kinase as a novel regulator of the Hippo pathway.
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Introduction
The Hippo pathway was initially discovered in Drosophila mel-
anogaster more than a decade ago. Since its discovery, the con-
servation of the Hippo pathway’s function in mammals has
motivated intense study of its components (Huang et al., 2005;
Yu and Guan, 2013; Meng et al., 2016). Canonical Hippo signal-
ing begins with the activation of large tumor suppressor kinase
LATS1/2 (homologs of Drosophila Warts). This occurs via phos-
phorylation of hydrophobic motifs in LATS1/2 (threonine 1079
in LATS1, threonine 1049 in LATS2) by the upstream mammalian
Ste20-like kinase 1/2 (MST1/2, homolog of Drosophila Hpo),
and in its activation loop (serine 909 in LATS1, serine 872 in
LATS2) by subsequent auto-phosphorylation. Active LATS1/2
phosphorylates the two paralogous transcriptional co-activators
Yes-associated protein (YAP) and WW domain-containing transcrip-
tion regulator 1 (WWTR1/TAZ) (homologs of Drosophila Yorkie) at
their HxRxxS/T consensus motifs (Hao et al., 2008; Ni et al., 2015;
Hoa et al., 2016). In particular, phosphorylation of YAP at serine
127 by LATS1/2 is an indicator of inactive YAP. Phosphorylated YAP
is shuttled from the nucleus to the cytoplasm, where it is eventually
degraded by the proteasome (Dong et al., 2007). This core Hippo
pathway cascade is essential in translating a wide range of external
cues (e.g. cell-cell contact, mechanical stress, extracellular matrix
stiffness, and nutrient availability) into appropriate cellular
responses (e.g. proliferation, differentiation, and cell fate determin-
ation) (Hong et al., 2005; Dupont et al., 2011; Zhao et al., 2011,
2012; Yu et al., 2012, 2013; Aragona et al., 2013; Azzolin et al.,
2014; Park et al., 2015). Malfunctions of the Hippo pathway in vivo
alter tissue development, affect tissue regeneration, and accelerate
cancer progression in organs like the liver, pancreas, stomach, and
intestine (Harvey et al., 2013; Moroishi et al., 2015; Panciera et al.,
2017). It is, therefore, important to better understand the intrinsic
cellular regulation of the Hippo pathway, especially the activity of
LATS1/2 and YAP/TAZ.
Citron kinase (CIT), a serine/threonine kinase, was first identified
through a yeast two-hybrid experiment using GTP-bound Rho and
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Rac (Madaule et al., 1995). CIT protein contains multi-functional
domains including a kinase domain, a coiled-coil domain, a Rho-
binding domain, a zinc finger, a pleckstrin homology domain, and a
citron homology domain (CNH) (Madaule et al., 1998; D’Avino,
2017). The most well-studied function of CIT is its role as a scaffold
protein for the recruitment of the core cytokinetic machinery
(Madaule et al., 1998; Gruneberg et al., 2006; Gai et al., 2011;
Bassi et al., 2013). Depletion of CIT in mitotic cells prevents the
formation of the mid-body and leads to the formation of multinu-
cleated cells (D’Avino, 2017). Supporting an essential role for CIT
in vivo, the loss of Sticky, the Drosophila CIT homolog, significantly
reduces the size of the imaginal discs and induces hyperploidy in
the larval brain (Shandala et al., 2004). Mice lacking CIT have shorter
lifespans and suffer from severe brain defects due mainly to pro-
nounced cell death triggered by abnormal cytokinesis (Di Cunto
et al., 2000). More importantly, two groups have independently
uncovered several pathogenic variants in the gene encoding CIT from
microcephaly patients (Harding et al., 2016; Li et al., 2016). This sug-
gests that the function of CIT is conserved in Drosophila and humans.
Despite these published in vivo data that reveal the function
of CIT, the details of its molecular mechanisms in cellular phe-
nomena other than cytokinesis remain poorly understood. While
searching for novel regulators of the canonical Hippo pathway,
we noticed a potential connection to CIT (Moya and Halder,
2014). Here, we demonstrate that CIT is, indeed, a novel compo-
nent of the Hippo signaling network. CIT serves as a scaffold
protein that facilitates the interaction of LATS2 and YAP. CIT
interacts with LATS2 to directly inhibit its kinase activity by hin-
dering MST1’s phosphorylation of the LATS2 hydrophobic motif.
This inactivates LATS2 and activates YAP. We confirmed with
genetic interaction assays in Drosophila melanogaster that
Sticky (the Drosophila CIT homolog) and Warts (the Drosophila
LATS1/2 homolog) function in a common pathway to control
eye development.
Results
CIT physically interacts with YAP and LATS2
In a protein–protein interaction analysis, we identified CIT as
a candidate binding partner for purified YAP tagged with
streptavidin-binding peptide (SBP) (Supplementary Figure S1A
and Table S1) (Kim et al., 2016). Since CIT appeared in the lists
of overlapping ‘prey’ proteins baited by other Hippo compo-
nents in other Hippo proteomic studies (Kwon et al., 2013;
Wang et al., 2014; Toloczko et al., 2017), we wanted to confirm
any interactions between CIT and the Hippo pathway protein
network. First, we checked CIT and YAP, finding that HA-tagged
YAP is co-immunoprecipitated with Myc-tagged CIT (Figure 1A).
We next attempted to identify the binding domain for each
respective protein. After obtaining all available CIT and YAP
truncation mutants, we used them to repeat the co-
immunoprecipitation experiments (Supplementary Figure S1B
and C). We found that loss of a conserved PPxY motif within the
CIT C-terminus is sufficient to abolish the binding of CIT and YAP
(Figure 1B and C). We also found that YAP lacking its WW
domain can no longer pull-down CIT (Figure 1D). Next, we tested
the interaction between CIT and LATS1/2, upstream regulators
of YAP. Interestingly, we found that CIT binds strongly to LATS2
and weakly to LATS1 (Figure 1E) (Furth and Aylon, 2017).
Equally important, we confirmed the endogenous interaction
between CIT, LATS2 under attachment (AT) and detachment (DE)
conditions (Supplementary Figure S1D). Also, we used immuno-
precipitation with a set of serially truncated CIT mutants to map
the domains required for CIT binding to LATS2. As shown in
Figure 1F, we narrowed this region down to the area containing
the Rho binding domain (RBD) and the zinc finger pleckstrin
homology domain (ZF-PH). Since the deletion of each of these
domains alone is insufficient to alter the interaction between
CIT and LATS2 (Supplementary Figure S1E), we conclude that
the CIT RBD and ZF-PH domains act redundantly in the binding
of LATS2. Collectively, CIT interacts strongly with YAP and
LATS2, weakly with LATS1, at two different sites: the PPxY motif
for YAP and the RBD and ZF-PH domains for LATS2.
Full-length CIT functions as a scaffold that promotes the
YAP–LATS2 interaction
Given that all three proteins—YAP, LATS2, and CIT—are inter-
connected, we asked how the interaction of two of the three
proteins is affected when the third component is added. We
observed that adding Flag-YAP enhances the association
between Myc-CIT and HA-LATS2 (Figure 2A Lanes 1 and 4,
and 2B-i). Similarly, additional expression of HA-LATS2 increases
the level of Flag-YAP immunoprecipitated by Myc-CIT and vice
versa (Figure 2A Lanes 2 and 4, and 2B-ii). Also, Flag-YAP pulls
down HA-LATS2 more efficiently in the presence of Myc-CIT
(Figure 2A Lanes 3 and 4, and 2B-iii). This result suggests add-
ing the missing third component to a complex of two of the
three proteins strengthens the association of all three.
Alternatively, we examined the endogenous interaction of LATS2
and YAP in the absence of CIT. We employed the CRISPR/Cas9
system to stably knock out full-length CIT in retinal pigment epi-
thelial cells (RPE). Hereafter, we will refer to the resulting RPE
CIT-null cells as sgCIT and to the RPE control cells as sgCTR. We
performed experiments under two conditions—attached (AT)
and detached (DE). Consistent with the effect of CIT overexpres-
sion, we found that knockout of CIT reduces the binding affinity
of YAP to LATS2 under both attached and detached conditions
(Figure 2C).
Next, we hypothesized that CIT, YAP, and LATS2 form a stable
tripartite complex. To prove this, we designed a sequential
immunoprecipitation experiment with exogenous expression of
Flag-YAP, Myc-CIT, and HA-LATS2 in HEK293T cells (Figure 2D).
We reasoned that upon initial immunoprecipitation with Flag-
YAP, followed by elution with Flag peptide, three potential com-
plexes may exist in the eluate: (i) a bipartite complex of Myc-CIT
and Flag-YAP, (ii) a bipartite complex of HA-LATS2 and Flag-YAP,
and (iii) a tripartite complex of Myc-CIT, Flag-YAP, and HA-LATS2.
After the second immunoprecipitation with Myc-CIT, if HA-LATS2
forms a tripartite complex with Flag-YAP and Myc-CIT, we should
detect HA-LATS2 in the final eluate (Figure 2D). Indeed, we
detected HA-LATS2 together with Myc-CIT and Flag-YAP among
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the products of the second immunoprecipitation (Figure 2E).
Furthermore, we checked the subcellular localization of Flag-
tagged YAP and HA-tagged LATS2 while co-expressing them with
either GFP-tagged CIT or a GFP empty vector control
(Supplementary Figure S2). As previously reported, CIT shows a
discrete punctuate appearance (Supplementary Figure S2i and ii)
(Di Cunto et al., 1998). Interestingly, when YAP-LATS2 is co-
expressed with GFP-CIT, the resulting staining pattern consists of
Figure 1 CIT physically interacts with YAP and LATS2. (A) CIT was co-immunoprecipitated with YAP. Immuno-blotting for the HA tag showed
the presence of HA-YAP along with Myc-CIT. (B) Schematic describing the structure of full-length Myc-CIT with the PPxY motif, Myc-CIT C-ter-
minus (Myc-CIT Ct) from amino acid 955 to the last amino acid, and the Myc-CIT C-terminus with a deletion of its PPxY motif (Myc-CIT
CtΔPY). There is a conserved PPxY motif at the C-terminus of CIT in zebrafish (D. rerio), mouse (Mus. musculus), and human (H. sapiens). (C)
YAP interacted with CIT through the PPxY motif. The DNA constructs in B were used in a co-immunoprecipitation assay with Flag-YAP. Western
blot showed that Myc-CIT CtΔPY failed to interact with YAP. (D) CIT interacted with YAP through its WW domain. Full-length YAP (Flag-YAP FL)
and YAP with a deleted WW domain (Flag-YAPΔWW) were subjected to co-immunoprecipitation. Only Flag-YAP FL was pulled down by Myc-CIT.
(E) CIT interacted strongly with LATS2 and weakly with LATS1. Myc-CIT was co-transfected together with HA-LATS1 or HA-LATS2 into HEK293T
cells. Immunoprecipitation with Myc tag pulled down both HA-LATS1 and HA-LATS2. s.e., short exposure; l.e., long exposure. (F) LATS2 bound
to CIT through its RBD and ZF-PH. Serial truncated mutants of Myc-CIT including Ct, Nt, and ΔC were subjected to co-immunoprecipitation with
HA-LATS2. CIT fragments Ct, Nt, and ΔC were generated by deleting the sequence encoding the following amino acids (0–955), (955–2055),
and (1746–2055), respectively.
1008 j Tran et al.
D
ow
nloaded from
 https://academ
ic.oup.com
/jm
cb/article-abstract/11/11/1006/5379217 by U
niversity of Torino user on 16 January 2020
a few dotted structures overlapping with CIT-positive punctate.
We did not observe this pattern in the case of co-expression
with a GFP empty vector control (Supplementary Figure S2iii–
viii). These data further confirmed the existence of the CIT–
LATS2–YAP complex. Together, our data support a model in
which full-length CIT functions as a scaffold protein for the form-
ation of a stable CIT–LATS2–YAP complex.
CIT promotes YAP activity by inhibiting LATS2 kinase
So far, our data show CIT enhances the association between
YAP and LATS2. While LATS2 is known to phosphorylate and
inhibit YAP activity, we next asked how CIT affects YAP activity.
Before analyzing YAP activity, it is important to note that the
morphologies of RPE CIT-null cells and RPE control cells are dif-
ferent. RPE CIT-null cells show significantly more multinucleation
Figure 2 Full-length CIT functions as a scaffold for the YAP–LATS2 interaction. (A) Comparison of the binding affinity between bipartite and
tripartite complexes of Flag-YAP, HA-LATS2, and Myc-CIT. The indicated combinations were expressed in HEK293T cells. Antibodies against
the Myc tag and Flag tag were used for analysis. (B) Quantification of the immunoprecipitation experiment in A. (i) Protein level of LATS2
pulled down by CIT in the presence or absence of YAP. (ii) Protein level of YAP precipitated by CIT in the presence or absence of LATS2.
(iii) Protein level of LATS2 bound to YAP in the presence or absence of CIT. n = 3, unpaired student’s t-test, *P < 0.05, **P < 0.01, error
bars indicate the SEM. (C) Endogenous immunoprecipitation of YAP and LATS2 in RPE cells under the attached condition (AT, cells normally
attached to culture dishes) and the detached condition (DE, cells trypsinized and suspended for 1 h before the experiment). Endogenous
immunoprecipitation were performed in RPE control cells (sgCTR) and RPE CIT-null cells (sgCIT). (D) Sequential immunoprecipitation scheme
(sequential immunoprecipitation) of CIT–LATS2–YAP. (E) The western blot showing the result from D.
CIT interacts with and inhibits LATS2 j 1009
D
ow
nloaded from
 https://academ
ic.oup.com
/jm
cb/article-abstract/11/11/1006/5379217 by U
niversity of Torino user on 16 January 2020
than RPE control cells (Supplementary Figure S3A and B). RPE
CIT-null cells also grow more slowly than control cells
(Supplementary Figure S3C) and incorporate less BrdU
(Supplementary Figure S3D). These characteristics may be due
to CIT-depletion-induced cytokinesis failure (D’Avino, 2017).
Next, we measured YAP activity in RPE CIT-null cells using
three common assays: measurement of YAP phosphorylation at
serine 127, observation of YAP localization, and measurement
of the expression of YAP target genes. First, we found RPE CIT-
null cells (sgCIT) show higher levels of YAP phosphorylation at
serine 127 than RPE control cells (sgCTR) (Figure 3A and B).
Given that depletion of CIT reduces YAP–LATS2 interaction
under attachment and detachment conditions, we measured the
levels of phosphorylated YAP under the same conditions. We
saw a consistent increase in the level of YAP phosphorylation in
CIT-null attached cells; but when YAP was fully phosphorylated
under cell-detached conditions, CIT knockout did not further
elevate YAP phosphorylation (Figure 3C). These data suggest
that in the presence of LATS activating signals, the reduced
LATS–YAP binding caused by CIT knockout may not affect LATS-
enzymatic catalysis of YAP. This result raises the additional
question of when CIT knockout starts to affect YAP phosphoryl-
ation. Thus, we re-plated suspended RPE cells and measured
phosphorylated YAP at different time points. Interestingly, we
observed an increase in YAP phosphorylation induced by CIT
knockout at the middle stage of cell re-attachment (i.e. 4–8 h
after plating) (Figure 3D). We saw a similar pattern in the experi-
ment using Latrunculins B (LatB) to activate LATS kinase
(Supplementary Figure S4A). Based on these data, we reasoned
that CIT promotes YAP de-phosphorylation in the presence of
YAP-activating signals (Supplementary Figure S4B). Also, the
scaffolding activity of Citron for YAP and LATS2 is of unknown
functional significance, and does not seem connected to YAP
phosphorylation by LATS. Second, given that highly phosphory-
lated YAP is excluded from the cytoplasm, we analyzed YAP sub-
cellular localization through immuno-florescent staining. We
found that rather than completely excluding YAP from the cyto-
plasm, CIT depletion equalizes the amount of YAP in the nuclear
and cytoplasmic compartments, especially in multinucleated
cells (Figure 3E). We, therefore, compared the number of cells
with predominantly nuclear YAP (Nu) to the number of cells with
equal YAP distribution in the nucleus and cytoplasm (Nu =
Cyto). Among the RPE CIT-null cells, we found fewer Nu cells
than Nu = Cyto cells (Figure 3F). Third, we measured the mRNA
level of YAP-regulated genes (e.g. CTGF, CYR61, ANKRD1,
AMOTL2) in the absence of CIT and found significant reduction
in their expression (Figure 3G). Together, these data suggest CIT
promotes YAP activity.
The phosphorylation of YAP at serine 127 is mediated by
LATS1/2, as knockdown of LATS1/2 rescues the effect of CIT on
YAP phosphorylation (Figure 3H). A study from Ganem et al.
(2014) indicated that tetraploid cells generated by dihydrocyto-
chalasin B treatment or actin polymerization also show
enhanced LATS kinase activity and reduced YAP activity. Thus,
the decrease in YAP activity we observed upon CIT depletion
may result from a mitotic catastrophe. To rule out this possiblity,
we peformed a kinase assay to directly examine LATS2’s ability
to phosphorylate YAP. When we immunoprecipitated exogenous
HA-LATS2 from HEK293T cells with transient depletion of
endogenous CIT, we found increased phosphorylation of LATS2
at its hydrophobic motif. After adding YAP as substrate to the
LATS2 kinase reaction in vitro, we observed an increase in YAP
phosphorylated at serine 127 (Figure 3I). In contrast, HA-LATS2
precipitated from HEK293T cells overexpressing full-length CIT
leads to less LATS2 phosphorylation at the hydrophobic motif
and less phosphorylation of YAP at serine 127 (Figure 3J). These
results support our hypothesis that CIT directly interferes with
the ability of LATS2 kinase to phosphorylate YAP.
The CIT N-terminus interferes with MST1 phosphorylation of the
LATS2 hydrophobic motif
The above data allowed us to devise a model in which CIT
interacts with LATS2 to weaken its ability to phosphorylate YAP.
Next, we asked how CIT regulates the activity of LATS2. First,
we reasoned that the CIT interacting domain may be important
for CIT’s inhibition of LATS2 kinase. Therefore, we performed a
LATS2 kinase assay with a CIT N-terminus mutant lacking both
the YAP and LATS2 binding domains. Unexpectedly, we found
that this N-terminus mutant reduces the phosphorylation of
LATS2 at its hydrophobic motif and YAP at serine 127 to an
extent similar to full-length CIT (Figure 4A). Next, we purified
the CIT N-terminus and LATS2 separately and then combined
them in different ratios before re-evaluating LATS2 kinase activ-
ity in vitro. Since the CIT N-terminus itself contains a kinase
domain, we confirmed that the CIT kinase domain does not
phosphorylate YAP at serine 127 by itself (Figure 4B). Also, we
found that a CIT N-terminus with an Alanine in place of lysine
126 (CIT Nt K/A mut), a mutation known to produce a CIT
kinase-dead protein, failed to reduce the phosphorylation of
LATS2 at its hydrophobic motif (Supplementary Figure S5A)
(Di Cunto et al., 1998). We then observed that the wild-type CIT
N-terminus suppresses the phosphorylation of the LATS2 hydro-
phobic motif and the phosphorylation of YAP at serine 127
(Figure 4B). These data strongly support the conclusion that the
CIT N-terminus, which contains a kinase domain and a coiled-
coil domain, is the main factor that hinders LATS2 kinase activ-
ity, and this inhibition may require CIT kinase activity.
The phosphorylation of the LATS1/2 hydrophobic motif by
MST1/2 is a prerequisite for full activation of LATS1/2 kinase
(Ni et al., 2015). Thus, we next asked whether the CIT N-
terminus prevents the phosphorylation of LATS2 by MST1/2. To
answer this question, we co-expressed the CIT N-terminus with
MST1 and immunoprecipitated LATS2 to assess its phosphoryl-
ation status. Before this, we confirmed that the expression of
the CIT N-terminus alone reduces phosphorylation at the LATS2
hydrophobic motif and that the expression of MST alone
increases LATS2 phosphorylation at this site in a dose-
dependent manner (Figure 4C Lanes 1–5). We found that the
additional expression of the CIT N-terminus interferes with
MST1-mediated phosphorylation of the LATS2 hydrophobic
1010 j Tran et al.
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motif (Figure 4C Lanes 6 and 7). Of note, this inhibition does not
disrupt the interaction between LATS2 and MST1 (Figure 4D).
Since LATS1 is MST1’s substrate, we asked whether the CIT N-
terminus has a similar effect on LATS1. Indeed, we found the
CIT N-terminus strongly inhibited the MST1-mediated phosphor-
ylation of LATS1 at its hydrophobic motif (Supplementary
Figure 3 CIT promotes YAP activity by inhibiting LATS2 kinase. (A) Western blot comparing the level of phosphorylated YAP at serine 127
between RPE control cells (sgCTR) and RPE CIT-null cells (sgCIT). (B) The intensities of the YAP and phosphorylated YAP bands were quantified
with the ImageJ software, and the ratio between them was calculated. n = 3, error bars indicate SEM, **P < 0.01, unpaired student’s t-test.
(C) Western blot showing the level of YAP phosphorylated at serine 127 in RPE attached cells compared to RPE detached cells. (D) The level of
YAP phosphorylated at serine 127 when RPE detached cells were re-plated and harvested at the indicated time points. (E) Representative image
displaying YAP localization in RPE control cells (sgCTR) and RPE CIT-null cells (sgCIT). YAP, red. DAPI, blue. Scale bar, 50 μm. (F) Percentage of
RPE cells showing nuclear YAP (Nu) or YAP equally distributed between the nucleus and cytoplasm (Nu = Cyto) quantified by the ImageJ soft-
ware. At least 100 cells in total were taken from 5 to 6 random fields. n = 3, error bars indicate SEM, ***P < 0.001, unpaired student’s t-test.
(G) mRNA level of YAP target genes: CTGF and CYR61 (n = 3), AMOTL2, and ANKRD1 (n = 4). Error bars indicate SEM, ***P < 0.001, unpaired
student’s t-test. (H) Western blot showed that siRNA-mediated knockdown of LATS1/2 rescued the effect of CIT knockout on YAP phosphoryl-
ation. (I and J) Kinase assay measuring LATS2 and YAP as substrates in the absence of endogenous CIT (I) or upon overexpression of full-length
CIT (J). LATS2 was immunoprecipitated with an HA tag antibody and subjected to a kinase assay with His-YAP as a substrate and cold ATP.
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Figure S5B and C). From these results, we reasoned that the CIT
N-terminus is rendering the hydrophobic motif of LATS2
inaccessible to MST1. Based on our molecular data, we propose
the following model for CIT’s regulation of LATS2 and YAP
(Figure 4E). CIT has two independent functions: full-length CIT
mediates the interaction between LATS2 and YAP, while the CIT
N-terminus inhibits the MST1-mediated phosphorylation of the
LATS2 hydrophobic motif, inactivating LATS2 and eventually
blocking YAP suppression. In summary, we conclude that CIT
promotes YAP activity by inhibiting the MST1-induced activation
of LATS2 kinase.
CIT/sticky (sti) shows genetic interaction with warts (wts) in
Drosophila
The Drosophila homologs of LATS1/2 and CIT are encoded by
warts (wts) and sticky (sti), respectively. To determine whether
wts and sti are functionally related in vivo, we analyzed the gen-
etic interaction between them. We used the GAL4-UAS system
to examine the effects of sti RNAi in targeted tissues.
Knockdown of sti by UAS-sti RNAi1 and GMR-GAL4 in the devel-
oping eye induces a slight reduction in eye size (Figure 5A and
B). GMR-GAL4-mediated overexpression of wts (GMR>wts)
induces a strong reduction in eye size and roughening of the
Figure 4 The CIT N-terminus interferes with MST1’s phosphorylation of the LATS2 hydrophobic motif. (A) Kinase assay using LATS2 and YAP
as substrates when the CIT N-terminus (Myc-CIT Nt) and HA-LATS2 were co-expressed. HA-LATS2 was immunoprecipitated via its HA tag,
and then subjected to a kinase assay with His-YAP and cold ATP. (B) Kinase assay using LATS2 and YAP as substrates when LATS2 was com-
bined with the CIT N-terminus in vitro. SBP-LATS2 was pulled down using streptavidin beads, while Flag-CIT Nt was precipitated via its Flag
tag. The two proteins were combined and subjected to a kinase assay with His-YAP and cold ATP. (C) MST1-mediated phosphorylation of
the LATS2 hydrophobic motif in the presence of MST1 alone or MST1 with the CIT N-terminus (Myc-CIT Nt). HA-LATS2 was immunoprecipi-
tated via its HA tag, and LATS2 hydrophobic motif phosphorylation was assessed using a specific antibody. (D) The interaction between
MST1 and LATS2 when MST1 was expressed alone or in combination with the CIT N-terminus (Myc-CIT Nt). Flag-LATS2 was immunoprecipi-
tated via its Flag tag, and the level of bound MST1 was checked using a specific antibody. (E) Schematic describing the proposed mechan-
ism by which CIT inhibits LATS2 kinase and promotes YAP activity.
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eye surface (Figure 5D). Under this condition, sti RNAi1 consider-
ably suppresses the wts overexpression phenotype (Figure 5E
and M). Two other UAS-sti RNAi lines (sti RNAi2 and sti RNAi3)
also produce similar suppression of the wts overexpression
phenotype (Supplementary Figure S7B, C, and G). This
suppression by sti RNAi is not due to a titration of the GAL4 by
an additional copy of UAS, because UAS-GFP does not affect the
wts overexpression phenotype (Supplementary Figure S6C and
D). The rough eye phenotype caused by wts overexpression is
also suppressed by sti1/+ heterozygous mutation (Figure 5F and
Figure 5 Genetic interaction between sti and wts in Drosophila eye. (A–D) Genotypes used for the genetic interaction between sti and wts.
(A) GMR>+ control. (B) Sti knockdown by sti RNAi1 causes a slight reduction in eye size. (C) sti1/+ heterozygotes show normal eyes. (D) Wts
overexpression reduces eye size and causes severe roughness. (E) sti RNAi1 partially suppresses the Wts overexpression phenotypes. (F–H)
The Wts overexpression phenotypes are partially suppressed by sti1/+ (F), sti3/+ (G), or stiGS9053/+ (H). (I–L) Genetic interaction between sti
RNAi1 and wts RNAi. (I) GMR>+ control. (J) sti RNAi1 weakly reduces eye size. (K) wts RNAi increases eye size. (L) sti RNAi does not suppress
the wts RNAi phenotype. Scale bar, 100 μm. (M) Dot plot quantification of relative eye size in A–H. Red diamond spot indicates the average
size of eye. (N) Dot plot quantification of relative eye size in I–L. Red diamond spot indicates the average size of eye.
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M). We obtained similar results with two other heterozygous sti
mutants (sti3, stiGS9053) (Figure 5G, H, and M). Such genetic
interactions suggest Wts function may, at least in part, depend
on Sti. We then examined the epistatic relationship between the
sti and wts RNAi conditions. wts RNAi knockdown using GMR-
GAL4 increases eye size (Figure 5K), whereas sti RNAi1 slightly
decreases it (Figure 5J). Interestingly, double knockdown of sti
and wts (GMR> sti RNAi1, wts RNAi) results in similar phenotype
as wts RNAi alone (Figure 5L and N). This implies wts RNAi is
epistatic to the sti RNAi phenotype. Together, our results show
that sti genetically interacts with both gain and loss of wts
function.
Discussion
In this study, we reveal a new function for citron kinase in the
regulation of the Hippo pathway. We first demonstrate CIT
physically interacts with the core Hippo components YAP and
LATS2. CIT binds to YAP through its PPxY motif and to LATS2
through its RBD and ZF-PH. CIT forms a complex with YAP and
LATS2, and the co-expression of YAP–LATS2 together with CIT
enhances the interaction between YAP and LATS2.
Furthermore, CIT interacts with LATS2 to restrain its kinase
activity toward YAP. This occurs as the CIT N-terminus acts to
inhibit the MST1-mediated phosphorylation of LATS2 at its
hydrophobic motif without perturbing the physical interaction
between MST1 and LATS2. We propose the model (Figure 4E)
in which CIT’s inhibition of LATS2 kinase activity relies mainly
on the CIT N-terminus because overexpression of the CIT N-
terminus alone is sufficient to reduce LATS2 kinase activity
(Figure 4A). Although, the scaffolding function of CIT seems to
be dispensable for YAP phosphorylation by LATS2, our results
do not exclude a role for the CIT C-terminus as an important
binding domain. We reasoned that in one hand, enzyme-
catalyzed reaction do not require strong and stable interaction
between enzyme and substrate; on the other hand, CIT’s dual
role as a scaffold protein and a LATS2 inhibitor may mean it
acts differently over time. In conditions that favor LATS2 kinase
activity (e.g. cell detachment or serum starvation), CIT may
function solely as a scaffold protein for YAP and LATS2 inter-
action. In conditions that disfavor LATS2 kinase activity (e.g.
cell re-attachment or serum stimulation), CIT inhibits LATS2 to
promote YAP activity.
Drosophila Sti and mammalian CIT proteins consist of con-
served N-terminal kinase domain, coiled-coiled domain, and C-
terminal region (D’Avino et al., 2004). Hence we also examined
the relationship between CIT and the Hippo pathway in vivo
using the Drosophila eye model. We found that sticky (sti) and
warts (wts), the Drosophila homologs of CIT and LATS2, respect-
ively, function in a common pathway to control Drosophila eye
size. Our genetic data seem to be consistent with the proposed
dual functions of CIT, that is, direct inhibition of LATS2 phos-
phorylation by CIT N-terminus and stabilization of LATS2–YAP
interaction by CIT C-terminus (Figure 4E). According to this mod-
el, Drosophila Sti may antagonize Wts to promote eye growth
when there is a normal level of Wts. In the case of Wts
overexpression, a high level of ectopic Wts may override the
inhibitory effects of Sti/CIT N-terminus, hence dominantly inhi-
biting Yki activity. However, when Sti is depleted, the Wts–Yki
interaction may be impaired due to loss of Sti/CIT C-terminal
function, leading to the suppression of wts overexpression
effects. Conversely, when wts is knocked down, Yki activity will
be increased independent of the level of Sti, consistent with the
observation that wts is epistatic to sti. These data suggest that
functional relationships between Sti and Wts are influenced by
the level and activity of Wts. Several external cellular stimuli are
known to affect the kinase activity of LATS2/Wts. Thus, depend-
ing on the cellular context, different protein-protein networks
might control LATS2/Wts kinase activity to maintain cellular
homeostasis (Meng et al., 2016). We will further examine the
effects of CIT/Sti on LATS2/Wts in different cellular contexts in
the future.
Materials and methods
Cell culture
Retinal pigment epithelial cell (RPE) and Human embryonic
kidney 293T cell (HEK293T) were cultured in DMEM/F12 and
DMEM, respectively, supplemented with 10% FBS and 1% peni-
cillin/streptomycin.
Plasmid constructs
The following CIT plasmids Myc-CIT, Myc.mcherry.CIT FL,
Myc.mcherry.CITΔRBD, Myc-CIT-ΔN, Myc-CIT Ct, Myc-CIT Nt,
Myc-CITΔZF-PH, Myc-CITΔC, and Myc.mcherry.CIT KD were kindly
provided by Prof. Ferdinado Di Cunto (Gai et al., 2011). Based
on these constructs, we additionally generated Flag-CIT Nt,
Myc-CIT CtΔPY, and Flag-CIT Nt K/A mut. The GFP-CIT plasmid
was kindly provided by Prof. Shuh Narumiya (Madaule et al.,
1998).
CRISPR/Cas9 knockout of CIT
A single guide RNA (sgRNA) was designed according to protocol
(Hsu et al., 2013) and cloned into the lentiCRIPRv2 vector (Sanjana
et al., 2014). sgRNA plasmids were transfected into HEK293T cells
together with the packaging vectors pMD2.G and psPAX2.
Lentiviral supernatant was collected after two days and used to
infect RPE cells for 24 h. Infected RPE cells were selected using
3 μg/ml puromycin. To obtain RPE CIT-null cells, a single clone
was isolated and tested for CIT depletion by western blot. The sin-
gle guide sequence used for CIT is 5′-GTCAGAAGTCTTGTAGGTTG-3′
(human).
siRNA transfection
siRNA oligos were annealed and diluted to a final concentra-
tion of 20 μM. Cells were prepared at sparse conditions
(100000/60-cm dish) and transfected with either control siRNA
or siRNA against a target gene of interest using Lipofectamine
RNAiMax (Invitrogen) with a ratio of 6 μl siRNA:6 μl reagent in
400 μl Opti-MEM medium and incubated at room temperature
for 10 min. Transfected cells were analyzed after two days. The
siRNA oligo sequences used for control, CIT, LATS1, and LATS2
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were: CIT, 5′-ACGATGAGCTGCTAGAAAA-3′ (human); LATS2, 5′-
AAAGGCGTATGGCGAGTAG-3′ (human); universal control, 5′-CGT
ACGCGGAATACTTCGA-3′; LATS1, 5′-GTCTGCTTCATACATTCCTAA-3′.
Co-immunoprecipitation
The indicated DNA combinations were transiently transfected
into HEK293T cells with polyethylenimine (PEI) at a ratio of 1 μg
DNA:3 μl PEI. After 2 days, the cells were harvested and lysed
with lysis buffer (0.5% Triton X-100, 50 mM Tris-Cl, pH 8.0,
150 mM NaCl, and 1 mM EDTA). The extracted proteins were
diluted to 1 mg in 1 ml lysis buffer and incubated with 1–2 μg
antibodies overnight. Then, 20 μl protein A/G agarose beads
were added the next day, and the resulting mixture was rotated
for 1–2 h at 4°C, followed by three washes in lysis buffer.
Finally, the samples were boiled with Laemmli buffer and sub-
jected to western blotting.
Endogenous immunoprecipitation
RPE cells were trypsinized and suspended one hour prior to
immunoprecipitation using 1 mg of extracted protein in 1 ml
lysis buffer (0.5% Triton X-100, 50 mM Tris-Cl, pH 8.0, 150 mM
NaCl, 1 mM EDTA). In the case of endogenous immunoprecipita-
tion, the lysate was pre-cleared with 10 μl protein A/G agarose
beads for 1 h before incubating with the antibody. After this,
the samples were centrifuged at 12000 rpm for 3 min to
pellet all the beads. Then, the supernatant was collected and
incubated with 2 μg antibody overnight. The next day, 20 μl pro-
tein A/G agarose beads were added, rotated for 1 h, followed
by three washes with lysis buffer. Finally, the samples were
boiled with Laemmli buffer and subjected to western blotting.
Sequential immunoprecipitation
The indicated combinations were expressed in HEK293T cells.
The first immunoprecipitation step was performed according to
the co-immunoprecipitation protocol above. The immunoprecipi-
tation samples were eluted using elution buffer containing 20 μl
3× Flag peptide from a stock concentration of 5 mg/ml (Sigma)
in 2 ml washing buffer (0.1% Triton X-100, 50 mM Tris-Cl, pH
8.0, 150 mM NaCl, 1 mM EDTA, 1× protease inhibitors, and a
phosphatase inhibitor). Then 100 μl of elution buffer was added
to the samples, incubated for 30 min on ice, and gently mixed
every 10 min (or rotating at mode 15 speed 18 rpm). Then, the
samples were centrifuged at maximum speed for 1 min, the
supernatants were collected, and this was repeated several
times until all supernatant was collected for each immunopreci-
pitation sample. The second round of immunoprecipitation was
carried out using 1 μg antibody in 0.1% Triton X-100 buffer
overnight, followed by 1 h of 20 μl protein A/G bead incubation,
and three washes with 0.1% Triton X-100 buffer. Finally, the
samples were boiled with Laemmli buffer.
BrdU staining and counting
Cells were split one day prior to collection at 10000–15000
cells/35 cm dish. The day after, 5 μg/ml BrdU (stock 10 mg/ml,
2000×) was added, incubated for 2 h, then fixed with 4% PFA.
The nucleus was permeabilized with 2 N HCl. Cells were stained
with an antibody against BrdU, and their nuclei were stained
with DAPI. Seven different areas were photographed per cover-
slip, for which the number of cells positive for DAPI and BrdU
was counted. The percentage of cells positive for BrdU (BrdU+)
was calculated by dividing the number of BrdU-positive cells by
the number of DAPI-positive cells and multiplying by 100.
Kinase assay
HA-LATS2 and the indicated plasmid combinations were trans-
fected into HEK293T cells. Cells were lysed with 1× cell lysis
buffer (0.5% Triton X-100, 50 mM Tris-Cl, pH 7.5, 150 mM NaCl,
1 mM EDTA). Then, lysate was subjected to immunoprecipitation
with HA antibody overnight, followed by incubation with 20 μl
protein A/G agarose beads for 1 h the next day. The immuno-
precipitation samples were washed twice with 1× washing buf-
fer (0.5% Triton X-100, 50 mM Tris-Cl, pH 8.0, 150 mM NaCl,
1 mM EDTA), and twice with 1× kinase buffer (25 mM Tris, pH
7.5, 2 mM DTT, 10 mM MgCl2, 1× PAFS). For the kinase reac-
tion, 500 μM cold ATP, 10 μl purified his-YAP, and a volume of
1× kinase buffer was added to the 20 μl protein A/G agarose
beads to bring the final volume to 40 μl. Then, the samples
were incubated at 30°C for 30 min. Finally, the kinase reaction
was terminated by boiling with Laemmli buffer.
Antibodies
The following antibodies were used in our study: HA
(Covance, MMS-101P), Flag (Sigma, F1804), Myc (Santa Cruz, sc-
40), Myc (ascite), IgG Mouse (Santa Cruz, sc-2025), CIT (Santa
Cruz, sc-390437), and YAP (Novus H00010431-M01) for immu-
nostaining and immunoprecipitation; Yap (Cell Signaling 4912 s)
for western blotting; pYAP S127 (Cell Signaling, 4911 s), LATS1
(Benthyl, A300-477A), LATS2 (Cell Signaling, 5888 s), β-actin
(Sigma, A5361), pLATS 1079 (Cell Signaling, 8654), pLATS 909
(Cell Signaling, 9157 s), MST1 (Cell Signaling, 3682), MST2 (Cell
Signaling, 3952 s), and BrdU (BD555627).
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RNA isolation and analysis
Cells were lysed using Easy-Blue (Intron Biotechnology) and
their RNA was purified according to the manufacturer’s instruc-
tions. Briefly, 2 μg RNA was heated to 70°C for 5 min and then
subjected to reverse transcription for 2 h using M-MLV reverse
transcriptase, oligo-dT, and random hexamer primers. Then, 1 μl
of cDNA was used as a template for quantitative PCR. Target
mRNA levels were normalized with the mRNA level of GAPDH.
The qPCR primers used for the target genes were: (human)
hGAPDH qF, 5′-CTTCGCTCTCTGCTCCTCCT-3′; hGAPDH qR, 5′-GTT
AAAAGCAGCCCTGGTGA-3′; (human) hCTGF qF, 5′-AAAAGTGCATC
CGTACTCCCA-3′; hCTGF qR, 5′-CCGTCGGTACATACTCCACAG-3′;
(human) hCYR61 qF, 5′-CCAATGACAACGCCTCCTG-3′; hCYR61 qR,
5′-TGGTGCAGCCAGAAAGCTC-3′; (human) hAMOTL2 qF, 5′-GCATT
GAGAAGCTGGAAAGC-3′; hAMOTL2 qR, 5′-CTTGTTCCGCATGGTCT
TCT-3′; (human) hANKRD1 qF, 5′-AGTAGAGGAACTGGTCACTGG-3′;
hANKRD1 qR, 5′-TGGGCTAGAAGTGTCTTCAGAT-3′.
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Mass spectrometry for identification of YAP binding proteins
RPE cells stably expressing YAP-tagged streptavidin binding
protein (SBP) or the SBP tag alone (control) were trypsinzed
and suspended for 1 h before being harvested and lysed with
0.5% Triton X-100. The lysates were pulled down and resolved
by SDS-PAGE before being subjected to silver staining.
Drosophila genetics
Drosophila stocks were maintained at 25°C. The GAL4-UAS sys-
tem (Brand and Perrimon, 1993) was used for gene overexpres-
sion or knockdown. Genetic crosses were made at 25°C unless
stated otherwise. w1118 was used as wild-type. GAL4 and UAS
lines were: GMR-GAL4 (Bloomington Drosophila Stock Center),
UAS-sti RNAiHMJ03025 (Bloomington Stock Center, BL64012, sti
RNAi1 in short), UAS-sti RNAiNIG10522R-1 (National Institute of
Genetics, NIG 10522R-1, sti RNAi2), UAS-sti RNAiNIG10522R-2 (NIG
10522R-2, sti RNAi3), UAS-wts RNAi (Vienna Drosophila Research
Center, v9928), and UAS-wts (a gift from G. Halder). sti1, sti3, and
stiGS9053 mutants were obtained from the Bloomington stock cen-
ter (BL4366, BL4871) and the Kyoto stock Center (DGRC201488),
respectively. Eye sizes were measured using the Image J soft-
ware. Dot plot graphs were generated using the R language in
the RStudio IDE with the ggplot2 package.
Statistical analysis
Graphs were created using GraphPad Prism 6. Statistical ana-
lysis was performed using two-tailed student’s t-tests with a
confidence level of 95%.
Supplementary material
Supplementary material is available at Journal of Molecular
Cell Biology online.
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